Scynexis Inc - Company & Market Research Reports

SCYNEXIS is a drug development company that develops and commercializes anti-infectives to address unmet therapeutic needs. Its lead product candidate, SCY-078, is a novel and structurally distinct triterpenoid glucan synthase inhibitor. SCY-078 is in Phase 2 clinical development as an oral and intravenous drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. Founded in 1999, the company is headquartered in Jersey City, New Jersey.

Hepatitis Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Hepatitis Drug Development Pipeline Review, 2018

  • Report
  • 133 Pages
From
Candidiasis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments - Product Thumbnail Image

Candidiasis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • Report
  • 95 Pages
From
Hepatitis B - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatitis B - Pipeline Review, H1 2018

  • Drug Pipelines
  • 365 Pages
From
Mycoses Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Mycoses Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 492 Pages
From
Global Antifungal Drugs Market Analysis & Trends - Industry Forecast to 2025 - Product Thumbnail Image

Global Antifungal Drugs Market Analysis & Trends - Industry Forecast to 2025

  • Report
  • 159 Pages
From
Global Antifungal infection Therapeutics Market Analysis & Trends - Drug Type (Allylamines, Polyenes, Echinocandins and Azoles) - Forecast to 2025 - Product Thumbnail Image

Global Antifungal infection Therapeutics Market Analysis & Trends - Drug Type (Allylamines, Polyenes, Echinocandins and Azoles) - Forecast to 2025

  • Report
  • 140 Pages
From
Aspergillosis Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Aspergillosis Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 115 Pages
From
Antifungal Drugs Market by Drug Type - Global Opportunity Analysis and Industry Forecast, 2017-2023 - Product Thumbnail Image

Antifungal Drugs Market by Drug Type - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Report
  • 190 Pages
From
African Trypanosomiasis R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

African Trypanosomiasis R&D Pipeline Analysis Report, H2-2018

  • Report
  • 40 Pages
From
Candidiasis R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Candidiasis R&D Pipeline Analysis Report, H2-2018

  • Report
  • 140 Pages
From
Candidiasis - Pipeline Review, H2 2018 - Product Thumbnail Image

Candidiasis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 162 Pages
From
African Trypanosomiasis - Pipeline Review, H2 2018 - Product Thumbnail Image

African Trypanosomiasis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 48 Pages
From
Aspergillosis - Pipeline Review, H1 2018 - Product Thumbnail Image

Aspergillosis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 128 Pages
From
African Trypanosomiasis - Pipeline Review, H1 2018 - Product Thumbnail Image

African Trypanosomiasis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 48 Pages
From
Candidiasis - Pipeline Review, H1 2018 - Product Thumbnail Image

Candidiasis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 172 Pages
From
Aspergillosis - Pipeline Review, H2 2017 - Product Thumbnail Image

Aspergillosis - Pipeline Review, H2 2017

  • Drug Pipelines
  • 108 Pages
From
Vulvovaginal Candidiasis - Pipeline Insight, 2018 - Product Thumbnail Image

Vulvovaginal Candidiasis - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Pharmaceutical Contract Manufacturing - Global Strategic Business Report - Product Thumbnail Image

Pharmaceutical Contract Manufacturing - Global Strategic Business Report

  • Report
  • 346 Pages
From
Candidiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Candidiasis - Product Thumbnail Image

Candidiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Candidiasis

  • Report
  • 65 Pages
From
African Trypanosomiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for African Trypanosomiasis - Product Thumbnail Image

African Trypanosomiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for African Trypanosomiasis

  • Report
  • 65 Pages
From
Loading Indicator
adroll